标题
Glycopyrronium/Formoterol: A Review in COPD
作者
关键词
-
出版物
DRUGS
Volume 79, Issue 13, Pages 1455-1466
出版商
Springer Science and Business Media LLC
发表日期
2019-08-29
DOI
10.1007/s40265-019-01186-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD
- (2019) François Maltais et al. ADVANCES IN THERAPY
- Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology
- (2018) Glyn Taylor et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology
- (2018) Gary T. Ferguson et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Randomized study of the effects of Aerochamber Plus ® Flow-Vu ® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease
- (2018) Faisal Fakih et al. RESPIRATORY MEDICINE
- Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
- (2018) Gary T Ferguson et al. International Journal of Chronic Obstructive Pulmonary Disease
- Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects
- (2018) Colin Reisner et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD
- (2018) Wilfried De Backer et al. International Journal of Chronic Obstructive Pulmonary Disease
- Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA
- (2018) Brian J Lipworth et al. International Journal of Chronic Obstructive Pulmonary Disease
- An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease
- (2018) Krishna Pudi et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
- (2018) Mohamed Ismail Abdul Aziz et al. International Journal of Chronic Obstructive Pulmonary Disease
- Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
- (2017) Nicola A. Hanania et al. RESPIRATORY MEDICINE
- A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD
- (2016) Donald P. Tashkin et al. RESPIRATORY MEDICINE
- Inhaled Glycopyrronium Bromide: A Review of its Use in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
- (2013) Natalie J. Carter DRUGS
- Budesonide/Formoterol Turbuhaler®
- (2012) Lesley J. Scott DRUGS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now